Yingsheng Biology
Latest round
- Series C
Last raised
- Mar 2022
Total raised
- Undisclosed
Investors
- 12
About Yingsheng Biology
Based in Ji'nan, China and established in 2009, Yingsheng Biology is a biotechnology enterprise that focuses on medical testing research and development, equipment production and sales. The company has built a gene detection platform and mass spectrometry detection platform around metabonomics and genomics. The company has obtained more than 20 national patents and 6 software copyrights. Meanwhile, the company cooperates with companies such as Thermo Fisher of the United States, Hamilton of Switzerland, and Biotage of Sweden. They have built a platform technology development and achievement transformation center for mass spectrometry, molecule, and pathology, such as Yingsheng-Thermo Fisher Scientific Mass Spectrometry Localization Production Center, Yingsheng-Thermo Fisher Scientific International R&D and Transformation Center. In 2020, the company developed the new crown detection reagent. In 2019, the company established strategic cooperation with Thermo Fisher. The company's main products are mass spectrometric detection instruments and diagnostic reagents, including high performance liquid chromatography-tandem mass spectrometry detection system, inductively coupled plasma mass spectrometer, mass spectrometry automatic intelligent processing platform, screening reagents for 48 genetic metabolic diseases of newborns. Besides, the company also provides third-party genetic testing and mass spectrometer detection services. The company's revenue is generated by providing mass spectrometric detection instruments, diagnostic reagents and medical testing services. In 2022, The company plans to achieve an Initial Public Offering.
Who invested in Yingsheng Biology
12 investors across 4 rounds
See all investors in Yingsheng Biology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Yingsheng Biology
Who invested in Yingsheng Biology?
Yingsheng Biology has 12 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Yingsheng Biology raised?
Yingsheng Biology has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Yingsheng Biology last raise money?
Yingsheng Biology's most recent round on record is a Series C, in Mar 2022.
What does Yingsheng Biology do?
Based in Ji'nan, China and established in 2009, Yingsheng Biology is a biotechnology enterprise that focuses on medical testing research and development, equipment production and sales.
Where is Yingsheng Biology headquartered?
Yingsheng Biology is headquartered in Jinan, China.
Which VCs invest in companies like Yingsheng Biology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Yingsheng Biology's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Yingsheng Biology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.